Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
β Scribed by Shahin Akhondzadeh; Sara Jafari; Firoozeh Raisi; Abbas Ali Nasehi; Aboulfazl Ghoreishi; Bahman Salehi; Soodeh Mohebbi-Rasa; Maedeh Raznahan; Abbas Kamalipour
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 91 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.20589
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, doubleβblind, placeboβcontrolled trial co
Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio
## Objectives: To determine the response of physically ill elderly depressed patients to treatment. ## Design: Acute geriatric medical inpatients with depression, randomly assigned to an 8-week double-blind placebo-controlled trial of fluoxetine. ## Main outcome measure: Response rate as define
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex
Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the